Novel and convenient synthesis of substituted quinolines by copper- or palladium-catalyzed cyclodehydration of 1-(2-aminoaryl)-2-yn-1-ols

Journal of Organic Chemistry

Volumn 72, Issue 18, 2007, Pages 6873-6877

  Gabriele, Bartolo ^a   Mancuso, Raffaella ^a   Salerno, Giuseppe ^a   Ruffolo, Giuseppe ^a   Plastina, Pierluigi ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; COPPER; DEHYDRATION; PALLADIUM; REACTION KINETICS; SYNTHESIS (CHEMICAL);

ALKYNYLMAGNESIUM BROMIDE; CYCLODEHYDRATION; HETEROANNULATION REACTIONS; QUINOLINES;

AROMATIC COMPOUNDS;

COPPER; COPPER CHLORIDE; KETONE DERIVATIVE; MAGNESIUM DERIVATIVE; PALLADIUM; QUINOLINE DERIVATIVE; SOLVENT;

ANNULATION REACTION; ARTICLE; CATALYSIS; CYCLIZATION; GRIGNARD REACTION; PURIFICATION; STEREOCHEMISTRY; SYNTHESIS;

AMINATION; CATALYSIS; COPPER; CYCLIZATION; MOLECULAR STRUCTURE; PALLADIUM; QUINOLINES; WATER;

EID: 34548770580     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo071094z     Document Type: Article

References (97)

1. For recent examples, see: (a) Kym, P. R.; Kort, M. E.; Coghlan, M. J.; Moore, J. L.; Tang, R.; Ratajczyk, J. D.; Larson, D. P.; Elmore, S. W.; Pratt, J. K.; Stashko, M. A.; Falls, H. D.; Lin, C. W.; Nakane, M.; Miller, L.; Tyree, C. M.; Miner, J. N.; Jacobson, P. B.; Wilcox, D. M.; Nguyen, P.; Lane, B. C. J. Med. Chem. 2003, 46, 1016-1030.
2. (b) Elmore, S. W.; Coghlan, M. J.; Anderson, D. D.; Pratt, J. K.; Green, B. E.; Wang, A. X.; Stashko, M. A.; Lin, C. W.; Tyree, C. M.; Miner, J. N.; Jacobson, P. B.; Wilcox, D. M.; Lane, B. C. J. Med. Chem. 2001, 44, 4481-4491.
3. (c) Savini, L.; Chiasserini, L.; Pellerano, C.; Filippelli, W.; Falcone, G. Farmaco 2001, 56, 939-945.
4. (d) Falk, S.; Goggel, R.; Heydasch, U.; Brasch, F.; Muller, K. M.; Wendel, A.; Uhlig, S. Am. J. Resp. Crit. Care 1999, 160, 1734-1742.
5. For recent examples, see: (a) Narender, P.; Srinivas, U.; Ravinder, M.; Rao, B. A.; Ramesh, C.; Harakishore, K.; Gangadasu, B.; Murthy, U. S. N.; Rao, V. J. Bioorg. Med. Chem. 2006, 14, 4600-4609.
6. (b) Holla, B. S.; Poojary, K. N.; Poojary, B.; Bhat, K. S.; Kumari, N. S. Indian J. Chem. B 2005, 44, 2114-2119.
7. (c) Sadana, A. K.; Mirza, Y.; Aneja, K. R.; Prakash, O. Eur. J. Med. Chem. 2003, 38, 533-536.
8. (d) Kumar, R. N.; Suresh, T.; Mohan, P. S. Indian J. Chem. B 2003, 42, 688-689.
9. (e) Kidwai, M.; Bhushan, K. R.; Sapra, P.; Saxena, R. K.; Gupta, R. Bioorg. Med. Chem. 2000, 8, 69-72.
10. (f) Fujita, M.; Chiba, K.; Tominaga, Y.; Hino, K. Chem. Pharm. Bull. 1998, 46, 787-796.
11. (g) Kayirere, M. G.; Mahamoud, A.; Chevalier, J.; Soyfer, J. C.; Cremieux, A.; Barbe, J. Eur. J. Med. Chem. 1998, 33, 55-63.
12. See, for example: (a) Tempone, A. G.; da Silva, A. C. M. P.; Brandt, C. A.; Martinez, F. S.; Borborema, S. E. T.; da Silveira, M. A. B.; de Andrade, H. F. Antimicrob. Agents Chemother. 2005, 49, 1076-1080.
13. (b) Franck, X.; Fournet, A.; Prina, E.; Mahieux, R.; Hocquemiller, R.; Figadere, B. Bioorg. Med. Chem. Lett. 2004, 14, 3635-3638.
14. (c) Sahu, N. P.; Pal, C.; Mandal, N. B.; Banerjee, S.; Raha, M.; Kundu, A. P.; Basu, A.; Ghosh, M.; Roy, K.; Bandyopadhyay, S. Bioorg. Med. Chem. 2002, 10, 1687-1694.
15. (d) Chiari, E.; Oliveira, A. B.; Prado, M. A. F.; Alves, R. J.; Galvão, L. M. C.; Araujo, F. G. Antimicrob. Agents Chemother. 1996, 40, 613-615.
16. (e) Fournet, A.; Barrios, A. A.; Munoz, V.; Hocquemiller, R.; Cave, A.; Bruneton, J. Antimicrob. Agents Chemother. 1993, 37, 859-863.
17. For recent examples, see: (a) Joshi, A. A.; Viswanathan, C. L. Bioorg. Med. Chem. Lett. 2006, 16, 2613-2617.
18. (b) Joshi, A. A.; Narkhede, S. S.; Viswanathan, C. L. Bioorg. Med. Chem. Lett. 2006, 15, 73-76.
19. (c) Dow, G. S.; Koenig, M. L.; Wolf, L.; Gerena, L.; Lopez-Sanchez, M.; Hudson, T. H.; Bhattacharjee, A. K. Antimicrob. Agents Chemother. 2004, 48, 2624-2632.
20. (d) Portela, C.; Afonso, C. M. M.; Pinta, M. M. M.; Ramos, M. J. Bioorg. Med. Chem. 2004, 12, 3313-3321.
21. (e) Ziegler, J.; Linck, R.; Wright, D. W. Curr. Med. Chem. 2001, 8, 171-189.
22. (f) Billker, O.; Lindo, V.; Panico, M.; Etienne, A. E.; Paxton, T.; Dell, A.; Rogers, M.; Sinden, R. E.; Morris, H. R. Nature 1998, 392, 289-292.
23. (g) Ismail, F. M. D.; Dascombe, M. J.; Carr, P.; Merette, S. A. M.; Rouault, P. J. Pharm. Pharmacol. 1998, 50, 483-492.
24. (h) Go, M. L.; Ngiam, T. L.; Tan, A. L. C.; Kuaha, K.; Wilairat, P. Eur. J. Pharm. Sci. 1998, 6, 19-26.
25. See, for example: (a) Heitsch, H. Curr. Med. Chem. 2002, 9, 913-928.
26. (b) Buccellati, C.; Fumagalli, F.; Viappiani, S.; Folco, G. Farmaco 2002, 57, 235-242.
27. (c) Dubé, D.; Blouin, M.; Brideau, C.; Chan, C. C.; Desmarais, S.; Ethier, D.; Falgueyret, J. P.; Friesen, R. W.; Girard, M.; Girard, Y.; Guay, J.; Riendeau, D.; Tagari, P.; Young, R. N. Bioorg. Med. Chem. Lett. 1998, 8, 1255-1260.
28. For recent examples, see: (a) Nayyar, A.; Malde, A.; Jain, R. Coutinho, E. Bioorg. Med. Chem. 2006, 14, 847-856.
29. (b) Nayyar, A.; Jain, R. Curr. Med. Chem. 2005, 12, 1873-1886.
30. (c) Monga, V.; Nayyar, A.; Vaitilingam, B.; Palde, P. B.; Jhamb, S. S.; Kaur, S.; Singh, P. P.; Jain, R. Bioorg. Med. Chem. 2004, 12, 6465-6472 (correction: 2005, 13, 1879)
31. (d) Vangapamdu, S.; Jain, M.; Jain, R.; Kaur, S.; Singh, P. P. Bioorg. Med. Chem. 2004, 12, 2501-2508.
32. (e) Jain, R.; Vaitilingam, B.; Nayyar, A.; Palde, P. B. Bioorg. Med. Chem. Lett. 2003, 13, 1051-1054.
33. See, for example: (a) Camps, P.; Gómez, E.; Muñoz-Torrero, D.; Badia, A.; Vivas, N. M.; Barril, X.; Orozco, M.; Luque, F. J. J. Med. Chem. 2001, 44, 4733-4736.
34. (b) Camps, P.; El Achab, R.; Morral, J.; Muñoz-Torrero, D.; Badia, A.; Baños, J. E.; Vivas, N. M.; Barril, X.; Orozco, M.; Luque, F. J. J. Med. Chem. 2000, 43, 4657-4666.
35. (c) Suzuki, T.; Usui, T.; Oka, M.; Suzuki, T.; Kataoka, T. Chem. Pharm. Bull. 1998, 46, 1265-1273.
36. See, for example: (a) Muruganantham, N.; Sivakumar, R.; Anbalagan, N.; Gunasekaran, V.; Leonard, J. T. Biol. Pharm. Bull. 2004, 27, 1683-1687.
37. (b) Bradbury, R. H.; Allott, C. P.; Dennis, M.; Girdwood, J. A.; Kenny, P. W.; Major, J. S.; Oldham, A. A.; Ratcliffe, A. H.; Rivett, J. E.; Roberts, D. A.; Robins, P. J. J. Med. Chem. 1993, 36, 1245-1254.
38. (a) Rossiter, S.; Peron, J. M.; Whitfield, P. J.; Jones, K. Bioorg. Med. Chem. Lett. 2005, 15, 4806-4808.
39. (b) Kalluraya, B.; Sreenivasa, S. Farmaco 1998, 53, 399-404.
40. See, for example: (a) Franck, X.; Fournet, A.; Prina, E.; Mahieux, R.; Hocquemiller, R.; Figadere, B. Bioorg. Med. Chem. Lett. 2004, 14, 3635-3638.
41. (b) Bénard, C.; Zouhiri, F.; Normand-Bayle, M.; Danet, M.; Desmaële, D.; Leh, H.; Mouscadet, J. F.; Mbemba, G.; Thomas, C. M.; Bonnenfant, S.; Le, Bret, M.; d'Angelo, J. Bioorg. Med. Chem. Lett. 2004, 14, 2473-2476.
42. (c) Fakhfakh, M. A.; Fournet, A.; Prina, E.; Mouscadet, J. F.; Franck, X.; Hocquemiller, R.; Figadere, B. Bioorg. Med. Chem. 2003, 11, 5013-5023.
43. (d) Fournet, A.; Mahieux, R.; Fakhfakh, M. A.; Franck, X.; Hocquemiller, R.; Figadere, B. Bioorg. Med. Chem. Lett. 2003, 13, 891-894.
44. (e) Zouhiri, F.; Desmaele, D.; d'Angelo, J.; Ourevitch, M.; Mouscadet, J. F.; Leh, H.; Le Bret, M. Tetrahedron Lett. 2001, 42, 8189-8192.
45. See, for example: (a) Tsotinis, A.; Vlachou, M.; Zouroudis, S.; Jeney, A.; Timar, F.; Thurston, D. E.; Roussakis, C. Lett. Drug Des. Discov. 2005, 2, 189-192.
46. (b) Martirosyan, A. R.; Rahim-Bata, R.; Freeman, A. B.; Clarke, C. D.; Howard, R. L.; Strobl, J. S. Biochem. Pharmacol. 2004, 68, 1729-1738.
47. (c) Perzyna, A.; Klupsch, F.; Houssin, R.; Pommery, N.; Lemoine, A.; Hénichart, J. P. Bioorg. Med. Chem. Lett. 2004, 14, 2363-2365.
48. (d) Abadi, A. H.; Brun, R. Arzneimittel-Forsch. 2003, 53, 655-663.
49. (e) Charris, J.; Martinez, P.; Dominguez, J.; Lopez, S.; Angel, J.; Espinoza, G. Heterocycl. Commun. 2003, 9, 251-256.
50. (f) Lamazzi, C.; Leonce, S.; Pfeiffer, B.; Renard, P.; Guillaumet, G.; Rees, C. W.; Besson, T. Bioorg. Med. Chem. Lett. 2000, 10, 2183-2185.
51. (g) Osiadacz, J.; Kaczmarek, L.; Opolski, A.; Wietrzyk, J.; Marcinkowska, E.; Biernacka, K.; Radzikowski, C.; Jon, M.; Peczynska-Czoch, W. Anticancer Res. 1999, 19, 3333-3342.
52. (h) Kaczmarek, L.; Peczynska-Czoch, W.; Osiadacz, J.; Mordarski, M.; Sokalski, W. A.; Boratynski, J.; Marcinkowska, E.; Glazman-Kusnierczyk, H.; Radzikowski, C. Bioorg. Med. Chem. Lett. 1999, 7, 2457-2464.
53. (i) Peczynskaczoch, W.; Pognan, F.; Kaczmarek, L.; Boratynski, J. J. Med. Chem. 1994, 37, 3503-3510.
54. For an excellent recent review, see: (a) Kouznetsov, V. V.; Méndez, L. Y. V.; Gómez, C. M. M. Curr. Org. Chem. 2005, 9, 141-161.
55. For some very recent developments in the synthesis of quinolines, see: (b) Ichikawa, J.; Sakoda, K.; Moriyama, H.; Wada, Y. Synthesis 2006, 1590-1598.
56. (c) Couturier, M.; Le, T. Org. Process Res. Dev. 2006, 10, 534-538.
57. (d) Janza, B.; Studer, A. Org. Lett. 2006, 8, 1875-1878.
58. (e) Lin, X. F.; Cui, S. L.; Wang, Y. G. Tetrahedron Lett. 2006, 47, 3127-3130.
59. (f) Chaudhuri, M. K.; Hussain, S. J. Chem. Sci. 2006, 118, 199-202.
60. (g) Chabert, J. F. D.; Chatelain, G.; Pellet-Rostaing, S.; Bouchu, D.; Lemaire, M. Tetrahedron Lett. 2006, 47, 1015-1018.
61. (h) Wang, G. W.; Jia, C. S.; Dong, Y. W. Tetrahedron Lett. 2006, 47, 1059-1063.
62. (i) Tanaka, S. Y.; Yasuda, M.; Baba, A. J. Org. Chem. 2006, 71, 800-803.
63. (j) Jia, C. S.; Zhang, Z.; Tu, S. J.; Wang, G. W. Org. Biomol. Chem. 2006, 4, 104-110.
64. (k) Wu, J.; Xia, H. G.; Gao, K. Org. Biomol. Chem. 2006, 4, 126-129.
65. (l) Morel, A. F., Larghi, E. L., Selvero, M. M. Synlett 2005, 2755-2758.
66. (m) Yadav, J. S.; Rao, P. P.; Sreenu, D.; Rao, R. S.; Kumar, V. N.; Nagaiah, K.; Prasad, A. R. Tetrahedron Lett. 2005, 46, 7249-7253.
67. (n) Rodriguez, J. G.; Rios, C. D. L.; Lafuente, A. Tetrahedron 2005, 61, 9042-9051.
68. (o) Kosiecka, M., Maslankiewicz, A.; Maslankiewicz, M. J., Heterocycles 2005, 65, 1577-1588.
69. (p) Zhang, X. X.; Campo, M. A.; Yao, T. L.; Larock, R. C. Org. Lett. 2005, 7, 763-766.
70. (q) Chelucci, G.; Manca, A.; Pinna, G. A. Tetrahedron Lett. 2005, 46, 767-770.
71. (r) Karthikeyan, G.; Perumal, P. T. J. Heterocycl. Chem. 2004, 41, 1039-1041.
72. For recent leading examples, see: (a) Jia, C. S.; Wang, G. W. Lett. Org. Chem. 2006, 3, 289-291.
73. (b) Cho, C. S.; Ren, W. X.; Shim, S. C. Bull. Kor. Chem. Soc 2005, 26, 2038-2040.
74. (c) Bose, D. S.; Kumar, R. K. Tetrahedron Lett. 2006, 47, 813-816.
75. (d) Wu, J.; Zhang, L.; Diao, T. N. Synlett 2005, 2653-2657.
76. (e) Cho, C. S.; Ren, W. X.; Shim, S. C. Bull. Kor. Chem. Soc. 2005, 26, 1286-1288.
77. (f) Cho, C. S.; Seok, H. J.; Shim, S. C. J. Heterocycl. Chem. 2005, 42, 1219-1222.
78. (g) Abbiati, G.; Arcadi, A.; Canevari, V.; Capezzuto, L.; Rossi, E. J. Org. Chem. 2005, 70, 6454-6460.
79. (h) Taguchi, K.; Sakaguchi, S.; Ishii, Y. Tetrahedron Lett. 2005, 46, 4539-4542.
80. (i) Martinez, R.; Brand, G. J.; Ramon, D. J.; Yus, M. Tetrahedron Lett. 2005, 46, 3683-3686.
81. (j) Arumugam, P.; Karthikeyan, G.; Atchudan, R.; Muralidharan, D.; Perumal, P. T. Chem. Lett. 2005, 34, 314-315.
82. (k) De, S. K.; Gibbs, R. A. Tetrahedron Lett. 2005, 46, 1647-1649.
83. (l) Igarashi, T.; Inada, T.; Sekioka, T.; Nakajima, T.; Shimizu, I. Chem. Lett. 2005, 34, 106-107.
84. The formation of 6-chloro-2-cyclopropyl-4-trifluoromethylquinolin-5-ol from 3-amino-6-chloro-2-(3-cyclopropyl-1-hydroxy-1-trifluoromethylprop-2-ynyl) phenol, obtained in situ by deprotection of the corresponding tert-butyldimethylsilyl ether with TBAF, has been briefly mentioned in the literature as an undesired reaction, but no further experimental details (including the product yield) have been given for this reaction: (a) Markwalder, J. A.; Mutlib, D. D. C. A.; Cordova, B. C., Klabe, R. M.; Seitz, S. P. Bioorg. Med. Chem. Lett. 2001, 11, 619-622.
85. Formation of 6-chloro-2-cyclopropyl-4-trifluoromethylquinoline in 81% yield by refluxing a solution of 2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1- trifluorobut-3-yn-2-ol in chlorobenzene for 6 h has also been reported: (b) Choudhury, A.; Pierce, M. E.; Confalone, P. N. Synth. Commun. 2001, 31, 3707-3714.
86. The iodocyclization of 1-(2-dimethylaminophenyl)-2-yn-1-ols to give 4-hydroxy-3-iodo-1,1-dimethyl-1,4-dihydroquinolinium iodides, which, upon heating, underwent formal loss of MeOH to give 3-iodo-1-methylquinolinium iodides has been recently reported: Hessian, K. O.; Flynn, B. L. Org. Lett. 2006, 8, 243-246.
87. For a recent review, see: Gabriele, B.; Salerno, G.; Costa, M. Synlett 2004, 2468-2483.
88. (a) Gabriele, B.; Salerno, G.; Lauria, E. J. Org. Chem. 1999, 64, 7687-7692.
89. (b) Gabriele, B.; Salerno, G. Chem. Commun. 1997, 1083-1084.
90. Gabriele, B.; Salerno, G.; Fazio, A. Org. Lett. 2000, 2, 351-352.
91. (a) Gabriele, B.; Salerno, G.; Fazio, A. J. Org. Chem. 2003, 68, 7853-7861.
92. (b) Gabriele, B.; Salerno, G.; Fazio, A.; Bossio, M. R. Tetrahedron Lett. 2001, 42, 1339-1341.
93. Gabriele, B.; Salerno, G.; Fazio, A.; Pittelli, R. Tetrahedron 2003, 59, 6251-6259.
94. Unidentified chromatographically immobile materials were formed as a result of decomposition.
95. 24 (see the Supporting Information for details). It is worth noting that in this latter case the authors have indicated the structure of the mononitrated product as 5-methoxy-2-nitroacetophenone rather than 3-methoxy-2-nitroacetophenone. The reduction of 3-methoxy-2-nitroacetophenone to give 2-amino-3-methoxyacetophenone was carried out as described in ref 24.
96. Alford, E. J., Irving, H.; Marsh, H. S.; Schofield, K. J. Chem. Soc. 1952, 3009-3017.
97. Robbins, R. J.; Laman, D. M.; Falvey, D. E. J. Am. Chem. Soc. 1996, 118, 8127-8135.